Skip to main content

Advertisement

Advertisement

Advertisement

Advertisement

ADVERTISEMENT

Fractures and the Use of Bisphosphonates in Patients With Breast Cancer

In an interview with Oncology Learning Network, Julie R. Gralow, MD, Clinical Director, Breast Medical Oncology, Seattle Cancer Care Alliance, Washington, discussed findings from the SWOG S0307 trial, which looked at the occurrence of fractures in patients with breast cancer receiving high-dose bisphosphonates to prevent metastases.

 

Advertisement

Advertisement

Advertisement

Advertisement